Berberine: Blood Sugar Trials, Side Effects
Berberine evidence: a meta-analysis of 46 trials in type 2 diabetes, how it compared with metformin in a small pilot, side effects, and what is unproven.
Researched from published studies and manufacturer specifications, checked .
We have not tested products ourselves. How we research
Quick verdict
Berberine lowered HbA1c and fasting glucose in a meta-analysis of 46 trials, all in people with type 2 diabetes. We found no trial showing a longevity benefit in people without diabetes. A third of patients in one pilot had gastrointestinal side effects. It can interact with medicines and may not suit everyone. Ask your doctor.
Talk to your doctor first. This is general information, not medical advice. Supplements and devices can interact with medicines and health conditions. We quote study protocols for context and do not recommend doses.
The short answer: berberine lowers HbA1c and fasting glucose in people with type 2 diabetes: a meta-analysis of 46 randomised trials found mean reductions of 0.73 in HbA1c and 0.86 in fasting glucose. We found no trial showing benefit for longevity in people without diabetes. In one pilot, about a third of patients had transient gastrointestinal side effects. It can interact with medicines. Talk to your doctor before taking it, especially alongside diabetes drugs.
What the evidence shows
Grades follow the rubric.
| Question | Grade | Evidence | Limit |
|---|---|---|---|
| Blood sugar in type 2 diabetes | Moderate | 46 RCTs: HbA1c MD -0.73, fasting glucose MD -0.86, 2-hour postprandial glucose also lower | Trial quality varies; many trials added berberine to standard care |
| Versus metformin | Weak | Yin 2008, study A: 36 adults with newly diagnosed diabetes, berberine or metformin (0.5 g three times a day) for 3 months; authors found similar glucose-lowering; HbA1c 9.5% to 7.5% on berberine | 36 people, 3 months, a pilot |
| Safety | Weak | Same pilot: 20 patients (34.5%) had transient GI side effects; no functional liver or kidney damage seen (the abstract does not give the denominator) | Short and small |
| Healthy people, longevity | Not shown | None found | Extrapolation from diabetes trials is not evidence |
For the head-to-head with the prescription drug see berberine vs metformin. Berberine is a Moderate-grade compound only for glucose in diabetes; where it sits among the others is in the graded supplement ladder. Products: Thorne Berberine (we did not verify its price or contents; Amazon link, we may earn a commission). Related: metformin and longevity, glucose monitoring.
Beyond blood sugar: cholesterol and interactions
- Cholesterol. A 2023 meta-analysis of 18 placebo-controlled trials (1,788 adults, 4 to 24 weeks, 83% in China or Hong Kong) found berberine lowered LDL cholesterol by 0.46 mmol/L, total cholesterol by 0.48 mmol/L and triglycerides by 0.34 mmol/L. Short trials; not a substitute for prescribed lipid treatment.
- Drug interactions. A 2026 narrative review says berberine should be treated as an active pharmacological agent, not an inert supplement: it inhibits CYP3A4 and other enzymes and modulates transporters, and in kidney-transplant recipients it raised cyclosporine exposure (AUC up 34.5%). The interactions are documented in humans for only a few drugs and are mechanistic for most.
Price at the dose used in a trial
Read from each brand’s product page on 29 Sept 2026, USD, before shipping. The dose is the one Yin 2008 used (0.5 g three times a day, 1.5 g a day); it is what that pilot used, not a recommendation.
| Product | Price | Per capsule | Cost of 1.5 g a day for 30 days |
|---|---|---|---|
| Nutricost Berberine Capsules | $20.97 for 60 | 600 mg berberine HCl | $26.21 (2.5 capsules a day, our arithmetic) |
| Double Wood Berberine | $19.95 | 500 mg berberine HCl; label allows up to 3 capsules a day | Not calculated: bottle count not readable on the page |
| Momentous Berberine | $49.99 for 60 servings | 550 mg as Berbevis phytosome | Not calculated: a different formulation, not comparable to the trial’s salt |
Testing statements: Nutricost states third-party testing by ISO-accredited laboratories; Double Wood states HPLC verification on every batch; we did not check any certificate.
Who it suits, who should skip it
Might be worth discussing with a doctor if you have type 2 diabetes, are already under care, and want to ask about berberine alongside your treatment. See berberine vs metformin.
Skip it, or ask a pharmacist first, if you take diabetes drugs, cyclosporine or other narrow-therapeutic-index medicines, are pregnant, or want it as a longevity supplement: no trial shows that.
Method note
Read for this page: Berberine and metabolic profiles in type 2 diabetes, systematic review and meta-analysis of RCTs (Oxid Med Cell Longev 2021); Efficacy of berberine in patients with type 2 diabetes mellitus, pilot study (Metabolism 2008); Berberine for dyslipidemia in adults, systematic review and meta-analysis of placebo-controlled RCTs (Drugs 2023), and 4 more listed above. Checked 29 Sept 2026. Abstracts only; grades are our judgement using the published rubric. We did not test any product. General information, not medical advice: this page gives no dose advice, only the dose used in a named trial.
Common questions
Does berberine lower blood sugar?
In people with type 2 diabetes, yes on average: a 2021 meta-analysis of 46 RCTs found reductions in HbA1c (mean difference -0.73) and fasting plasma glucose (-0.86), with berberine used alone or with standard therapy. Trials were mostly in China and often of modest quality.
What are the side effects of berberine?
In Yin 2008, 20 patients (34.5%) had transient gastrointestinal adverse effects during the trial, and no functional liver or kidney damage was seen. Berberine can interact with medicines, so ask your doctor or pharmacist, particularly if you take diabetes drugs, and do not use it in pregnancy without medical advice.
Sources
- Berberine and metabolic profiles in type 2 diabetes, systematic review and meta-analysis of RCTs (Oxid Med Cell Longev 2021) checked 29 Sept 2026
- Efficacy of berberine in patients with type 2 diabetes mellitus, pilot study (Metabolism 2008) checked 29 Sept 2026
- Berberine for dyslipidemia in adults, systematic review and meta-analysis of placebo-controlled RCTs (Drugs 2023) checked 29 Sept 2026
- Berberine-drug interactions: mechanisms, clinical relevance and risk stratification, narrative review (Pharmaceuticals 2026) checked 29 Sept 2026
- Nutricost Berberine Capsules product page ($20.97, 60 capsules of 600 mg berberine HCl) checked 29 Sept 2026
- Double Wood Berberine product page ($19.95, 500 mg berberine HCl per capsule) checked 29 Sept 2026
- Momentous Berberine product page ($49.99, 550 mg Berbevis phytosome, 60 servings) checked 29 Sept 2026
Update log
- Expansion: added the 2023 dyslipidemia meta-analysis, the 2026 drug-interaction review, a price table with cost at the dose used in Yin 2008, and a decision box.
- Sourcing pass: replaced unsourced claims and dosing advice with a 46-trial meta-analysis and the Yin 2008 pilot, both in people with type 2 diabetes; removed brand rankings and product prices we could not verify.
Data and comparisons
- Berberine evidence record
Often called "natural metformin"
- NMN evidence record
A direct NAD+ precursor that restores declining NAD+ levels with age
- Resveratrol evidence record
A polyphenol that activates sirtuins (SIRT1)
Related reading
Berberine vs Metformin: What Trials Compare
Berberine vs metformin: one 36-person pilot found similar glucose lowering; metformin is a prescription drug and neither is proven to extend life.
NMN: Legal Status, NMN vs NR, What Trials Show
Is NMN legal in the US supplement market, how does it compare with NR, what human trials found, and what a month costs at the dose those trials used.
CoQ10 and Ubiquinol: What Trials Show, and Cost
CoQ10 evidence: Q-SYMBIO in heart failure patients, mixed statin-muscle-pain meta-analyses, ubiquinol vs ubiquinone, and monthly cost at the trial dose.
Curcumin: Arthritis Trials, Not Longevity
Curcumin: a meta-analysis of 29 RCTs found improved pain and inflammation in arthritis, with low-quality trials; no evidence it extends life.